Scott M. Herrig
Lawyers
Filters
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition
Barnes Group $750 million senior secured notes offering
The high-yield notes are part of the financing for an Apollo-led investor group’s acquisition of Barnes
Sabre $800 million exchange offer and $775 million term loan exchange
We are advising Sabre on the exchange offers
Arthur J. Gallagher $13.45 billion AssuredPartners bridge acquisition financing
We advised the lead arrangers and agent on the bridge facility
PL Developments exchange offer and consent solicitation
The exchange offer included the issuance of new PIK toggle senior secured notes due 2029
Cleveland-Cliffs $1.8 billion notes offering
We advised Cleveland-Cliffs on the offering
Ryan Specialty $600 million notes offering and $3.1 billion credit facilities
The company also obtained a $500 million bridge facility commitment
SS&C Technologies $670 million acquisition of Battea-Class Action Services
We are advising SS&C on the transaction
Cleveland-Cliffs $600 million notes offering
We advised Cleveland-Cliffs on the offering